ArticleBMC pulmonary medicine2026
Frailty, depressive symptoms, and incident respiratory disease: a CHARLS cohort study.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAgeing populations face a rising burden of asthma and chronic lung disease (CLD). We assessed whether frailty and depressive symptoms—and their changes—predict incident respiratory diseases.
methodsAdults ≥ 45 years from the China Health and Retirement Longitudinal Study (CHARLS) without asthma or CLD at baseline were followed. Multivariable logistic regression estimated odds ratios (ORs) for baseline frailty (per 0.1-unit increase), CES-D-10 depressive symptoms, and transitions across two waves. Dose–response was examined using smoothed curve fitting and threshold effect analysis. We tested the interaction between frailty and depressive symptoms and performed stratified analyses by depressive status. All models were adjusted for comprehensive covariates, including daily cigarette consumption and history of prior lung disease. Sensitivity analyses were conducted by excluding heavy smokers and using an onset-timing proxy respectively.
resultsDuring follow-up, 258 participants developed asthma and 702 developed CLD. In multivariable models, each 0.1-unit increase in the baseline frailty index was associated with a higher risk of asthma (OR = 1.222, 95% CI 1.081–1.381) and, more strongly, with CLD (OR = 1.291, 95% CI 1.190–1.402). For depressive symptoms, each 1-point increase was significantly associated with an increased risk of CLD (OR = 1.032, 95% CI 1.018–1.047), while the association with asthma was positive in direction but did not reach statistical significance (OR = 1.016, 95% CI 0.994–1.039). The interaction between frailty and depressive symptoms was statistically significant for CLD (p < 0.05) but not for asthma, suggesting a synergistic effect for CLD but independent effects for asthma. Smoothed curve fitting showed an approximately linear gradient for depressive symptoms with both outcomes; for FI, the asthma curve rose at low FI and then plateaued, whereas the FI–CLD curve was monotonically increasing. These associations remained robust in sensitivity analyses excluding heavy smokers.
conclusionsFrailty and depressive symptoms are key risk markers for incident respiratory disease in later life. Incorporating brief frailty assessment and depression screening into routine care may improve risk stratification and support upstream, multidisciplinary prevention for asthma and CLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.